PDCD1 and cancer: The impairment of immune cell function and aberrant expression of suppressor T cell response are widely recognized consequences of the interaction between programmed cell death protein-1 (PD-1) and its ligand, programmed cell death ligand-1 (PD-L1), in pathological conditions such as cancer and chronic infection (107).